GF Fund Management’s scPharmaceuticals SCPH Stock Holding History

GF Fund Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,147	Closed	-$6.5K	–	690
2025 Q3	$6.5K	Sell	1,147 -95	-8%	-$486	﹤0.01%	590
2025 Q2	$4.73K	Hold	1,242	–	–	﹤0.01%	630
2025 Q1	$3.27K	Buy	1,242 +191	+18%	+$622	﹤0.01%	639
2024 Q4	$3.72K	Buy	+1,051	New	+$4.03K	﹤0.01%	622

GF Fund Management's SCPH Position: Q4 2025 in Review

GF Fund Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 1,147 shares — an estimated $6.5K sold.

GF Fund Management first reported a position in SCPH in Q4 2024 and held it in 4 quarters. The position peaked at $6.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

GF Fund Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
GF Fund Management sold 1,147 scPharmaceuticals shares in Q4 2025, an estimated $6.5K.
GF Fund Management first reported a position in scPharmaceuticals in Q4 2024 and held it in 4 quarters.
GF Fund Management's scPharmaceuticals position peaked at $6.5K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.